These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 37444578)
1. The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. Mokhtari RB; Ashayeri N; Baghaie L; Sambi M; Satari K; Baluch N; Bosykh DA; Szewczuk MR; Chakraborty S Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444578 [TBL] [Abstract][Full Text] [Related]
2. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models. Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190 [TBL] [Abstract][Full Text] [Related]
3. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
4. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Miesfeld JB; Link BA Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909 [TBL] [Abstract][Full Text] [Related]
5. Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. Luo M; Xu Y; Chen H; Wu Y; Pang A; Hu J; Dong X; Che J; Yang H Eur J Med Chem; 2022 Dec; 244():114847. PubMed ID: 36265280 [TBL] [Abstract][Full Text] [Related]
6. Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling. Zhao B; Pobbati AV; Rubin BP; Stauffer S Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111340 [TBL] [Abstract][Full Text] [Related]
7. New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. Zhao Y; Sheldon M; Sun Y; Ma L Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067201 [TBL] [Abstract][Full Text] [Related]
8. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Crawford JJ; Bronner SM; Zbieg JR Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112 [No Abstract] [Full Text] [Related]
9. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857 [TBL] [Abstract][Full Text] [Related]
10. Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression. Mondal V; Higgins PJ; Samarakoon R Cancers (Basel); 2024 Aug; 16(15):. PubMed ID: 39123485 [TBL] [Abstract][Full Text] [Related]
11. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression. Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829 [TBL] [Abstract][Full Text] [Related]
12. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452 [TBL] [Abstract][Full Text] [Related]
13. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Pobbati AV; Hong W Theranostics; 2020; 10(8):3622-3635. PubMed ID: 32206112 [TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
15. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ. Kwon H; Kim J; Jho EH FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
17. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
18. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Kovar H; Bierbaumer L; Radic-Sarikas B Cells; 2020 Apr; 9(4):. PubMed ID: 32326412 [TBL] [Abstract][Full Text] [Related]
19. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. Holden JK; Cunningham CN Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29558384 [TBL] [Abstract][Full Text] [Related]
20. Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive Nouri K; Azad T; Ling M; Janse van Rensburg HJ; Pipchuk A; Shen H; Hao Y; Zhang J; Yang X Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]